Zobrazeno 1 - 10
of 111
pro vyhledávání: '"Julie A, Vincent"'
P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease
Autor:
Elisabeth A. Kaza, MD, Matthew C. Egalka, MD, Hairu Zhou, MS, Jianchun Chen, PhD, Denise Evans, MSHS, Jayne Prats, PhD, Ruizhi Li, PhD, Scott L. Diamond, PhD, Julie A. Vincent, MD, Emile A. Bacha, MD, Thomas G. Diacovo, MD
Publikováno v:
JACC: Basic to Translational Science, Vol 2, Iss 4, Pp 465-476 (2017)
Shunt thrombosis remains a major cause of morbidity and mortality, especially during the initial palliation for single-ventricle physiology. The authors present evidence that the P2Y12 inhibitor cangrelor may fill a therapeutic void in thromboprophyl
Externí odkaz:
https://doaj.org/article/c24f00b352584996bab90f96c7603ea7
Autor:
Nicole S. Klee, Cameron G. McCarthy, Steven Lewis, Jaine L. McKenzie, Julie E. Vincent, R. Clinton Webb
Publikováno v:
Frontiers in Surgery, Vol 5 (2018)
Diabetic bladder dysfunction (DBD) is a well-recognized and common symptom affecting up to 50% of all diabetic patients. DBD has a broad range of clinical presentations ranging from overactive to underactive bladder symptoms that develops in middle-a
Externí odkaz:
https://doaj.org/article/0b97945e848844bab76244536422bc8b
Autor:
Evan M. Zahn, Lars Søndergaard, Felix Berger, John P. Cheatham, Andreas Eicken, Julie A. Vincent, Jonathan J. Rome, Jacqueline Kreutzer, Shabana Shahanavaz, Shicheng Weng, Lisa Bergersen, Thomas K. Jones, Doff B. McElhinney, David T. Balzer
Publikováno v:
Shahanavaz, S, Berger, F, Jones, T K, Kreutzer, J, Vincent, J A, Eicken, A, Bergersen, L, Rome, J J, Zahn, E, Søndergaard, L, Cheatham, J P, Weng, S, Balzer, D & McElhinney, D 2020, ' Outcomes After Transcatheter Reintervention for Dysfunction of a Previously Implanted Transcatheter Pulmonary Valve ', JACC: Cardiovascular Interventions, vol. 13, no. 13, pp. 1529-1540 . https://doi.org/10.1016/j.jcin.2020.03.035
Objectives The aim of this analysis was to evaluate outcomes following transcatheter reintervention for degenerated transcatheter pulmonary valves (TPVs). Background TPV replacement (TPVR) with the Melody valve demonstrated sustained relief of right
Autor:
Te Hsin Lung, Andreas Eicken, Lee N. Benson, John F. Rhodes, Thomas M. Zellers, Daniel R. Turner, John W. Moore, Thomas K. Jones, Aimee K. Armstrong, Julie A. Vincent, Felix Berger, John P. Cheatham, Doff B. McElhinney
Publikováno v:
Catheterization and Cardiovascular Interventions. 94:607-617
OBJECTIVES To investigate whether age and valve size at implant contribute to outcomes after Melody transcatheter pulmonary valve replacement (TPVR). BACKGROUND Patient age and valve size at implant contribute to longevity of surgical pulmonary valve
Autor:
Thomas M. Zellers, Jonathan J. Rome, John P. Cheatham, Jacqueline Kreutzer, John W. Moore, Thomas K. Jones, Lisa Bergersen, Allison K. Cabalka, Daniel R. Turner, Aimee K. Armstrong, William E. Hellenbrand, Danyal Khan, Julie A. Vincent, Robert G. Gray, Shicheng Weng, David T. Balzer, Jeffrey D. Zampi, Alexander J. Javois, Doff B. McElhinney
Publikováno v:
Catheterization and Cardiovascular Interventions. 98
Objective We compared 5-year outcomes of transcatheter pulmonary valve (TPV) replacement with the Melody TPV in the post-approval study (PAS) and the investigational device exemption (IDE) trial. Background As a condition of approval of the Melody TP
Autor:
Arash Salavitabar, Mariel E. Turner, Julie A. Vincent, Matthew A. Crystal, Alejandro Torres, Usha Krishnan
Publikováno v:
Tex Heart Inst J
To investigate whether transcatheter device closure of patent ductus arteriosus (PDA) is safe in children with pulmonary artery hypertension, we retrospectively analyzed our experience with 33 patients who underwent the procedure from January 2000 th
Autor:
Joseph Schmidhofer, Justin Yeh, Jacqueline Kreutzer, Vivekanand Allada, Thomas G. Diacovo, Ganga Krishnamurthy, Victor O. Morell, Xinren Yu, Diana Vargas, Julie A. Vincent, Emile A. Bacha, Hairu Zhou, Scott L. Diamond
Publikováno v:
Circulation. 142
Background: Thrombotic events contribute significantly to early mortality in neonates with CHD requiring a systemic-to-pulmonary artery shunt. However, thromboprophylaxis remains suboptimal with few pharmacological agents studied and shown to be of b
Autor:
Kristin T, Oshiro, Mariel E, Turner, Alejandro J, Torres, Matthew A, Crystal, Julie A, Vincent, Oliver M, Barry
Publikováno v:
The Journal of invasive cardiology. 32(7)
COVID-19 has led to major changes in hospital systems across the world. In an effort to reduce viral transmission, conserve resources, and in accordance with institutional and state mandates, all elective procedures and surgeries were postponed durin
Autor:
Thomas K. Jones, Doff B. McElhinney, Julie A. Vincent, William E. Hellenbrand, John P. Cheatham, Darren P. Berman, Evan M. Zahn, Danyal M. Khan, John F. Rhodes, Shicheng Weng, Lisa J. Bergersen
Publikováno v:
Circulation. Cardiovascular Interventions
Supplemental Digital Content is available in the text.
Background: The Melody valve was developed to extend the useful life of previously implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves, while preservi
Background: The Melody valve was developed to extend the useful life of previously implanted right ventricular outflow tract (RVOT) conduits or bioprosthetic pulmonary valves, while preservi
P2Y12 Receptor Function and Response to Cangrelor in Neonates With Cyanotic Congenital Heart Disease
Autor:
Matthew Egalka, Hairu Zhou, Thomas G. Diacovo, Ruizhi Li, Elisabeth Kaza, Emile A. Bacha, Julie A. Vincent, Jayne Prats, Denise Evans, Scott L. Diamond, Jianchun Chen
Publikováno v:
JACC. Basic to translational science
JACC: Basic to Translational Science, Vol 2, Iss 4, Pp 465-476 (2017)
JACC: Basic to Translational Science, Vol 2, Iss 4, Pp 465-476 (2017)
SUMMERY Shunt thrombosis remains a major cause of morbidity and mortality, especially during the initial palliation for single-ventricle physiology. The authors present evidence that the P2Y12 inhibitor cangrelor may fill a therapeutic void in thromb